Literature DB >> 29522272

Presence of lytic Epstein-Barr virus infection in nasopharyngeal carcinoma.

Fenggang Yu1, Yanan Lu1, Fredrik Petersson2, De-Yun Wang1, Kwok Seng Loh1,3.   

Abstract

BACKGROUND: Chromogenic Epstein-Barr virus-encoded RNA (EBER) in situ hybridization (EBER-ISH) is the gold standard to detect Epstein-Barr virus (EBV) but it is difficult to use in conjunction with immunohistochemistry (IHC). In this study, our purpose was to validate the sensitivity and specificity of RNAscope in detection of EBV infection in nasal epithelium and its stroma.
METHODS: Fluorescence-based RNAscope EBER-ISH, BRLF1-ISH, and lineage marker-IHC were performed on archived formalin-fixed paraffin-embedded tissues from normal nasal cavity (n = 5), nasopharynx (n = 8), and nasopharyngeal carcinoma (NPC) specimens (n = 10).
RESULTS: The EBERs were detected in 10 of 10 NPC samples but was absent in all normal tissues from the nasal cavity and nasopharynx. The EBERs were exclusively located in pan-cytokeratin (pan-CK)-positive tumor epithelial cells but not in CD45-positive leukocytes and vimentin-positive stromal fibroblasts. The level of EBER expression varied in tumor cells within patient and between patients as well. Additionally, 5 of 10 patients had positive BRLF-ISH.
CONCLUSION: We developed a simple and reproducible method to simultaneously detect mRNA and protein in formalin-fixed paraffin-embedded tissues of NPC. As a single staining, traditional EBER continues to be useful; however, for interpretation of the phenotype of EBV-infected cells, RNAscope is superior. Significantly, we showed that lytic EBV infection took place in NPC tumors.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  BRLF1 gene; Epstein-Barr virus; Epstein-Barr virus-encoded RNA (EBER); RNAscope in situ hybridization; immunohistochemistry; nasopharyngeal carcinoma

Mesh:

Substances:

Year:  2018        PMID: 29522272     DOI: 10.1002/hed.25131

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

1.  Partial absence of PD-1 expression by tumor-infiltrating EBV-specific CD8+ T cells in EBV-driven lymphoepithelioma-like carcinoma.

Authors:  Yannick Simoni; Etienne Becht; Shamin Li; Chiew Yee Loh; Joe Poh Sheng Yeong; Tony Kiat Hon Lim; Angela Takano; Daniel Shao Weng Tan; Evan W Newell
Journal:  Clin Transl Immunology       Date:  2020-09-09

2.  A primary nasopharyngeal three-dimensional air-liquid interface cell culture model of the pseudostratified epithelium reveals differential donor- and cell type-specific susceptibility to Epstein-Barr virus infection.

Authors:  Phillip Ziegler; Yarong Tian; Yulong Bai; Sanna Abrahamsson; Alan Bäckerholm; Alex S Reznik; Anthony Green; John A Moore; Stella E Lee; Michael M Myerburg; Hyun Jung Park; Ka-Wei Tang; Kathy Ho Yen Shair
Journal:  PLoS Pathog       Date:  2021-04-29       Impact factor: 6.823

3.  Presence of Human Papillomavirus and Epstein-Barr Virus, but Absence of Merkel Cell Polyomavirus, in Head and Neck Cancer of Non-Smokers and Non-Drinkers.

Authors:  Frans J Mulder; Faisal Klufah; Famke M E Janssen; Farzaneh Farshadpour; Stefan M Willems; Remco de Bree; Axel Zur Hausen; Mari F C M van den Hout; Bernd Kremer; Ernst-Jan M Speel
Journal:  Front Oncol       Date:  2021-01-20       Impact factor: 6.244

4.  MYC-activated RNA N6-methyladenosine reader IGF2BP3 promotes cell proliferation and metastasis in nasopharyngeal carcinoma.

Authors:  Mingyu Du; Yi Peng; Yang Li; Wenyue Sun; Huanfeng Zhu; Jing Wu; Dan Zong; Lirong Wu; Xia He
Journal:  Cell Death Discov       Date:  2022-02-08

5.  Intralesional EBV-DNA load as marker of prognosis for nasopharyngeal cancer.

Authors:  Johan S Nilsson; Ola Forslund; Fredrik C Andersson; Malin Lindstedt; Lennart Greiff
Journal:  Sci Rep       Date:  2019-10-28       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.